This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Bristol Myers Squibb has served as a strategic partner for the Cancer Research Institute by providing unparalleled support to advance scientific research and educate patients about immunotherapy.
Their collaboration has supported the first online patient portal focused on immunotherapy (TheAnswerToCancer.org), multi-year title sponsorship of the Answer to Cancer cycling events, Cancer Immunotherapy and You webinar series, and Immunotherapy Patient Summit series, including the Inaugural Patient Summit. Bristol Myers Squibb has also supported the CRI Irvington Postdoctoral Fellowship Program, and the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.
In 2014, Bristol Myers Squibb’s leadership in the field of cancer immunotherapy was recognized with the Cancer Research Institute Oliver R. Grace Award, presented to Murdo Gordon, executive vice president and chief commercial officer, at the Cancer Research Institute Annual Awards Dinner.
Contact Us
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.
Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).